Analysis of the High-end Cellomics Market by Academic Research/Basic Research, and Drug Discovery
Revolutionizing the High-end Cellomics Market- Integrating Artificial Intelligence and Automation for Advanced Analysis and Precision Medicine. Uncover More with FMI
The high-end cellomics market revenue totaled US$ 325.1 million in 2023, according to Future Market Insights (FMI) study. The overall sales of high-end cellomics are expected to reach US$ 639.2 million by 2033, capturing a CAGR of 7% from 2023 to 2033.
Recent developments in drug discovery and high-end cellomics have augmented pressure at the strategic points along the drug discovery pipeline, auguring well for the market’s future trends. The rising need to determine and study toxicity levels in the initial phase of drug discovery is driving market growth.
How does the Development of Advanced Imaging Systems Augment High-end Cellomics Market Growth?
High-end cellomics has gained significant traction for its ability to investigate various aspects of cell biology and the drug discovery and development process.
Technological breakthroughs have been observed in automated microscope hardware, sCMOS cameras, confocal optics, oil immersion objective lenses, and throughput capabilities of these systems.
Advanced imaging systems have also improved software data analysis and data management capabilities.
Industry players are focusing on introducing new products with advanced features.
Molecular Devices LLC introduced the ImageXpress Confocal HT.ai High Content HT.ai high content screening system in January 2021. It enables researchers to accelerate their study on phenotypic screening of organoid models, offering benefits such as quick image acquisition and multiplexing flexibility.
In December 2020, Molecular Devices LLC introduced water imaging technology for the ImageXpress Micro Confocal High-Content Imaging System. This technology allows the acquisition and analysis of 3D cell model assays, including spheroids, organoids, and organ-on-chip biology.
The availability of innovative products with associated benefits is expected to drive the adoption and growth of the global high-end cellomics industry.
Attributes
Details
High-end Cellomics Market Value 2023
US$ 325.1 million
Estimated High-end Cellomics Market Value 2033
US$ 639.2 million
CAGR 2023 to 2033
7%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2018 to 2022 High-end Cellomics Demand Outlook Compared to 2023 to 2033 Forecast
According to Future Market Insights (FMI), the sales of high-end cellomics have expanded at a CAGR of 4.9% from 2018 to 2022.
The demand for effective screening methods and techniques has surged in the last decade due to the rising prevalence of several genetic disorders and neurological diseases. This had a positive impact on the high-end cellomics market. Furthermore, initiatives undertaken by governments to promote advanced biotechnology research increase the installation of high-end cellomics instruments for drug discovery applications.
Cities of India such as Bangalore, Pune, Hyderabad, and Tamil Nadu have well-established biotechnology research infrastructures recognized globally, which is predicted to soar the demand for high-end research instruments.
Apart from India, China, and the United States of America, the governments of Japan, Brazil, the United Kingdom, and Australia are supporting their domestic biotechnology and bioscience industry through similar initiatives, shaping the high-end cellomics market demand analysis.
What are the Key Opportunities for High-end Cellomics Market Players?
Expansion of applications: High-end cellomics market players have the opportunity to explore and expand the applications of their systems in various fields, such as drug discovery, personalized medicine, regenerative medicine, and disease research.
Technological Advancements: Continuous advancements in hardware, imaging technologies, data analysis software, and automation present opportunities for market players to develop and offer many advanced and efficient high-end cellomics systems.
Collaborations and Partnerships: Collaborating with pharmaceutical companies, research institutions, and contract research organizations (CROs) can create opportunities for market players to access a wider customer base and expand their market presence.
Emerging Markets: Market players can explore and tap into emerging markets, particularly in the region such as Asia Pacific and Latin America, where there is a growing demand for advanced technologies in life sciences research and drug discovery.
Customization and Tailored Solutions: Offering customizable solutions and tailored packages for specific research needs can attract customers and provide a competitive edge in the market.
Integration of Artificial Intelligence (AI): Incorporating AI algorithms and machine learning capabilities into high-end cellomics systems can enhance data analysis, improve accuracy, and provide many insightful results, opening up opportunities for market players to leverage these technologies.
Outsourcing Services: Providing high-quality high content screening (HCS) services to pharmaceutical companies, biotechnology firms, and academic institutions as a specialized service provider or CRO can be a significant opportunity for market players.
Market Education and Awareness: Educating potential customers about the benefits and potential applications of high-end cellomics systems through seminars, workshops, and publications can create opportunities for market players to expand their customer base and drive market growth.
Find your sweet spots for generating winning opportunities in this market.
Can a High Price of High-end Cellomics Instruments Limit their Widespread Adoption?
High-end cellomics instruments integrate automated microscopy, image processing, and visualization tools into a single system, but their advanced features contribute to their higher price range.
The total cost of ownership for high-end cellomics instruments includes not only the instrument cost but also expenses for installation, maintenance, and services.
Budgetary constraints among academic research institutes, contract research organizations (CROs), pharmaceutical, and biotechnology companies can hinder the adoption of high-end cellomics instruments.
In price-sensitive markets like India, there is a trend of shifting toward alternative cell imaging analysis equipment, such as cell imaging instruments and flow cytometry.
The high cost of high-end cellomics instruments, combined with the availability of alternative instruments, is anticipated to negatively impact market growth.
Comparative View of the High-end Cellomics Market
High-end Cellomics Market:
Attributes
High-end Cellomics Market
CAGR (2023 to 2033)
7%
Market Value (2033)
US$ 639.2 million
Opportunity
The growing interest in outsourcing services is anticipated to positively drive the sales of high-end cellomics systems, which in turn provides a key opportunity for market growth.
Key Trends
Increasing integration of artificial intelligence (AI) and machine learning technologies.
Specific Imaging Solution Market:
Attributes
Specific Imaging Solution Market
CAGR (2023 to 2033)
6.5%
Market Value (2033)
US$ 756.3 million
Opportunity
The imaging process is predicted to be automated and streamlined through the use of software-based value-added services powered by the Internet of Things (IoT) and data analytics, which can provide manufacturers with a key market opportunity.
Key Trends
Key market trends include an increase in chronic disease diagnoses, product technical breakthroughs, and corporate expansions through partnerships.
Molecular Imaging Market:
Attributes
Molecular Imaging Market
CAGR (2023 to 2033)
5.4%
Market Value (2033)
US$ 7.6 billion
Opportunity
The molecular imaging market is likely to witness profitable opportunities owing to the development of AI-based medical equipment.
Key Trends
The rise of hybrid imaging combines multiple imaging modalities for comprehensive and accurate diagnostic information.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-wise Insights
How Likely is the United States of America to Remain a Key Market for High-end Cellomics?
In 2022, the United States of America’s high-end cellomics market accounted for over 28.5% value share in North America.
Demand in the United States of America is primarily driven by a strong regional economy, the presence of refined research and healthcare facilities, and improved attention to overall health and well-being.
The country's supportive regulatory environment and access to funding further contribute to its position as a leading market for high-end cellomics.
How is Germany’s High-end Cellomics Market Projected to Fare?
Germany accounted for a 6.5% value share in 2022. Germany’s high-end cellomics market is projected to fare positively in the coming years.
Growing capital and venture investments for cellular research, technological developments in high-end cellomics solutions, cost restraint in pharma research and development, and the presence of key players have resulted in the high growth of Germany’s market.
What are the Factors Supporting High-end Cellomics Sales in Australia?
Australia’s market is anticipated to exhibit a 5.5% CAGR during the forecast period. The rising prevalence of neurodegenerative diseases such as Alzheimer’s and Parkinson’s is one of the key factors driving the market growth. Similarly, the growing geriatric population is supplementing market growth in Australia.
What Facilitates the Demand in India’s High-end Cellomics Market?
The market in India is expected to advance at 9.2% CAGR from 2023 to 2033. Research activities in the biotechnology and bioscience field are increasing notably due to government support and the availability of funds, thus increasing the demand for high-end cellomics in India.
The Government of India is offering 100% foreign direct investment for biotechnology companies that are based outside India, and the GOI is offering public-private partnerships for companies based in India.
The Department of Biotechnology has supported the biotechnology research infrastructure including high-end high content screening systems, flow cytometry, imaging microarray, and high-resolution mass spectrometry facilities in Delhi and Mumbai respectively.
What is the Scope for Sales of High-end Cellomics in China?
The market in China is projected to exhibit a 7.7% CAGR during the forecast period and is expected to contribute significantly to the market in East Asia region. Government initiatives to spur the biotechnology industry in the region are creating growth opportunities in China.
China has included the biotechnology industry as one of the strategic priorities for development in terms of technology. Moreover, there were about 95 biotech-related deals till June 2020, drawing about US$ 12 billion deals.
In 2020, Everest Medicines Ltd and Maxwell Biosciences Co. Ltd. raised US$ 310 million in June and US$ 279 million respectively. These companies have strong oncology and immunology products in their pipelines, which require advanced instrumentation such as high-end HCS systems in the drug discovery phase for screening and compound profiling.
Category-wise Insights
What are the Sales Prospects in Drug Discovery?
High-end cellomics demand in drug discovery consistently rises, registering a high share of 55.42% in 2022. Increasing support for research and development activities, particularly for rare diseases, and the growing use of informatics in drug discovery led to demand for Drug Discovery.
Why is Demand for High-end Cellomics High in Pharmaceutical & Biotechnology Companies?
Pharmaceutical & biotechnology companies are currently leading the market. This sub-segment accounted for 52.03% value share in 2022.
Pharmaceutical & biotechnology companies are using this informatics software widely for pre-clinical research & development, compound screening and lead documentation, target identification, and rationalization of their drug discovery process. It becomes the key factor for propelling the growth of the Pharmaceutical & Biotechnology Companies segment.
How is the Competitive Landscape Structured within the High-end Cellomics Industry?
The competitive landscape within the high-end cellomics market is structured with multiple key players vying for market share and differentiation. The market consists of several prominent companies that offer high-end cellomics solutions and compete for customers. These players may vary in terms of size, market presence, and product offerings.
Market players are actively focusing on developing high-end cellomics instruments to capitalize on the growing market opportunity. These systems have increased software data analysis and data management capabilities. Quick image acquisition and multiplexing flexibility with high-performing lasers and an improved incubation environment are some of the benefits offered by these systems.
A Few of the Strategies Employed by the Market Players Include
Product innovation and development
Strategic partnerships and collaborations
Market expansion and geographic reach
Targeted marketing and branding efforts
Customer-centric approach and personalized solutions
Continuous improvement of customer support and services
Competitive pricing strategies
Focus on regulatory compliance and quality standards
Acquisitions and mergers to strengthen market position
Investment in research and development capabilities
Key Players Working in the Market:
PerkinElmer, Inc.
ThermoFisher Scientific, Inc.
Molecular Devices LLC (part of Danaher Corporation)
Yokogawa Electric Corporation
Key Developments in the Market:
ImageXpress Confocal HT.ai High Content HT.ai. (Molecular Devices LLC), ImageXpress Micro Confocal High-Content Imaging System (with water imaging technology) (Molecular Devices LLC), and Cell Voyager CV8000 (Yokogawa) are some of the recent launches by the industry players in the global market.
High-end cellomics are increasingly using machine learning methods for data interpretation and image analysis. These algorithms can swiftly identify and quantify cellular characteristics, increasing analysis speed and precision.
Organ-on-a-chip technology integrates microfluidics, tissue engineering, and cell culture to mimic the functioning of human organs in a lab setting. This method enables the study of cellular responses and interactions under more physiologically appropriate settings, assisting in drug discovery and toxicity assessment.
High-end cellomics is making a substantial contribution to cancer research by offering insights into tumor heterogeneity, metastasis, and medication resistance. Cellular analysis tools have enabled the identification of cancer biomarkers, the characterization of circulating tumor cells, and the evaluation of therapeutic efficacy.
Market by Category
By Application:
Academic Research/Basic Research
Drug Discovery
Primary & Secondary Screening
Target Identification & Validation
Invitro Toxicity Studies
Compound Profiling
By End-User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Independent Contract Research Organizations (CROs)
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East and Africa (MEA)
Frequently Asked Questions
How Big is the High-end Cellomics Market?
The market is valued at US$ 325.1 million in 2023.
What is the Growth Potential of the Market?
The growth potential of the market is 7% through 2033.
Which Country Relishes Significant Market Share?
The United States market relishes 28.5% market share presently.
What is India’s Anticipated Growth Rate?
India is anticipated to expand at a CAGR of 9.2% through 2033.
How are Key Players Capitalizing on the Expanding Market?
Key players are focusing on creating high-end cellomics instruments to capitalize on the expanding market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
5.3.1. Academic Research/Basic Research
5.3.2. Drug Discovery
5.3.2.1. Primary & Secondary Screening
5.3.2.2. Target Identification & Validation
5.3.2.3. Invitro Toxicity Studies
5.3.2.4. Compound Profiling
5.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2023 to 2033
6.3.1. Pharmaceutical & Biotechnology Companies
6.3.2. Academic & Research Institutes
6.3.3. Independent Contract Research Organizations (CROs)
6.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. South Asia
7.3.5. East Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Application
8.2.3. By End-User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Application
8.3.3. By End-User
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Application
9.2.3. By End-User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Application
9.3.3. By End-User
9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. UK
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Application
10.2.3. By End-User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Application
10.3.3. By End-User
10.4. Key Takeaways
11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Malaysia
11.2.1.3. Singapore
11.2.1.4. Thailand
11.2.1.5. Rest of South Asia
11.2.2. By Application
11.2.3. By End-User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Application
11.3.3. By End-User
11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Application
12.2.3. By End-User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Application
12.3.3. By End-User
12.4. Key Takeaways
13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Application
13.2.3. By End-User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Application
13.3.3. By End-User
13.4. Key Takeaways
14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Application
14.2.3. By End-User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Application
14.3.3. By End-User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Application
15.1.2.2. By End-User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Application
15.2.2.2. By End-User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Application
15.3.2.2. By End-User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Application
15.4.2.2. By End-User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Application
15.5.2.2. By End-User
15.6. UK
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Application
15.6.2.2. By End-User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Application
15.7.2.2. By End-User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Application
15.8.2.2. By End-User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Application
15.9.2.2. By End-User
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Application
15.10.2.2. By End-User
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Application
15.11.2.2. By End-User
15.12. Singapore
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Application
15.12.2.2. By End-User
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Application
15.13.2.2. By End-User
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Application
15.14.2.2. By End-User
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Application
15.15.2.2. By End-User
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Application
15.16.2.2. By End-User
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Application
15.17.2.2. By End-User
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Application
15.18.2.2. By End-User
15.19. GCC Countries
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2022
15.19.2.1. By Application
15.19.2.2. By End-User
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2022
15.20.2.1. By Application
15.20.2.2. By End-User
15.21. Israel
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2022
15.21.2.1. By Application
15.21.2.2. By End-User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Application
16.3.3. By End-User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Thermo Fisher Scientific Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. GE Healthcare
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. BD Biosciences
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Olympus Corporation
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. PerkinElmer Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Merck KGaA
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Carl Zeiss AG
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Danaher Corporation
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Bio-Rad Laboratories, Inc.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Agilent Technologies, Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 11: Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 12: Europe Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 13: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: South Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 15: South Asia Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 16: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: East Asia Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 18: East Asia Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 20: Oceania Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 21: Oceania Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Table 22: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 23: MEA Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 24: MEA Market Value (US$ Million) Forecast by End-User, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Application, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by End-User, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 7: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 10: Global Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 11: Global Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 13: Global Market Attractiveness by Application, 2023 to 2033
Figure 14: Global Market Attractiveness by End-User, 2023 to 2033
Figure 15: Global Market Attractiveness by Region, 2023 to 2033
Figure 16: North America Market Value (US$ Million) by Application, 2023 to 2033
Figure 17: North America Market Value (US$ Million) by End-User, 2023 to 2033
Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 22: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 28: North America Market Attractiveness by Application, 2023 to 2033
Figure 29: North America Market Attractiveness by End-User, 2023 to 2033
Figure 30: North America Market Attractiveness by Country, 2023 to 2033
Figure 31: Latin America Market Value (US$ Million) by Application, 2023 to 2033
Figure 32: Latin America Market Value (US$ Million) by End-User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 37: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 40: Latin America Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 43: Latin America Market Attractiveness by Application, 2023 to 2033
Figure 44: Latin America Market Attractiveness by End-User, 2023 to 2033
Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 46: Europe Market Value (US$ Million) by Application, 2023 to 2033
Figure 47: Europe Market Value (US$ Million) by End-User, 2023 to 2033
Figure 48: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 52: Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 53: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 55: Europe Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 56: Europe Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 57: Europe Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 58: Europe Market Attractiveness by Application, 2023 to 2033
Figure 59: Europe Market Attractiveness by End-User, 2023 to 2033
Figure 60: Europe Market Attractiveness by Country, 2023 to 2033
Figure 61: South Asia Market Value (US$ Million) by Application, 2023 to 2033
Figure 62: South Asia Market Value (US$ Million) by End-User, 2023 to 2033
Figure 63: South Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 64: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 65: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 66: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 67: South Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 68: South Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 69: South Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 70: South Asia Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 71: South Asia Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 72: South Asia Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 73: South Asia Market Attractiveness by Application, 2023 to 2033
Figure 74: South Asia Market Attractiveness by End-User, 2023 to 2033
Figure 75: South Asia Market Attractiveness by Country, 2023 to 2033
Figure 76: East Asia Market Value (US$ Million) by Application, 2023 to 2033
Figure 77: East Asia Market Value (US$ Million) by End-User, 2023 to 2033
Figure 78: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 79: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 80: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 81: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 82: East Asia Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 83: East Asia Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 84: East Asia Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 85: East Asia Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 86: East Asia Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 88: East Asia Market Attractiveness by Application, 2023 to 2033
Figure 89: East Asia Market Attractiveness by End-User, 2023 to 2033
Figure 90: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 91: Oceania Market Value (US$ Million) by Application, 2023 to 2033
Figure 92: Oceania Market Value (US$ Million) by End-User, 2023 to 2033
Figure 93: Oceania Market Value (US$ Million) by Country, 2023 to 2033
Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 97: Oceania Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 98: Oceania Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 100: Oceania Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 101: Oceania Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 102: Oceania Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 103: Oceania Market Attractiveness by Application, 2023 to 2033
Figure 104: Oceania Market Attractiveness by End-User, 2023 to 2033
Figure 105: Oceania Market Attractiveness by Country, 2023 to 2033
Figure 106: MEA Market Value (US$ Million) by Application, 2023 to 2033
Figure 107: MEA Market Value (US$ Million) by End-User, 2023 to 2033
Figure 108: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 109: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 112: MEA Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 113: MEA Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 114: MEA Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 115: MEA Market Value (US$ Million) Analysis by End-User, 2018 to 2033
Figure 116: MEA Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033
Figure 117: MEA Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033
Figure 118: MEA Market Attractiveness by Application, 2023 to 2033
Figure 119: MEA Market Attractiveness by End-User, 2023 to 2033
Figure 120: MEA Market Attractiveness by Country, 2023 to 2033
